CDKN2A and neoplasm: Specifically, we observed gains or amplifications of Myc, Pdgfra, and Cdkn2a, or loss of Pten, all of which influence cell pathways involved in cell cycle regulation, metabolic rewiring, or stress response, and are heterogeneously present in tumor cells.